The effect of thiamine treatment on the activity of pyruvate dehydrogenase: relation of the treatment of Leigh's encephalomyelopathy.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001933:Brain Stem; D004678:Encephalomalacia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008607:Intellectual Disability / Q000188:drug therapy; D008293:Malates; D008930:Mitochondria, Liver / Q000032:analysis / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D009097:Multienzyme Complexes / Q000378:metabolism*; D010101:Oxygen Consumption; D011596:Psychomotor Disorders / Q000188:drug therapy; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D013577:Syndrome; D013831:Thiamine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D013835:Thiamine Pyrophosphate / Q000032:analysis / Q000502:physiology
D008293:Malates; D009097:Multienzyme Complexes; D011773:Pyruvates; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D013835:Thiamine Pyrophosphate; D013831:Thiamine